IL149443A0 - Compositions for treating viral diseases - Google Patents

Compositions for treating viral diseases

Info

Publication number
IL149443A0
IL149443A0 IL14944300A IL14944300A IL149443A0 IL 149443 A0 IL149443 A0 IL 149443A0 IL 14944300 A IL14944300 A IL 14944300A IL 14944300 A IL14944300 A IL 14944300A IL 149443 A0 IL149443 A0 IL 149443A0
Authority
IL
Israel
Prior art keywords
compositions
viral diseases
treating viral
treating
diseases
Prior art date
Application number
IL14944300A
Other languages
English (en)
Original Assignee
Advanced Immuni T Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Immuni T Inc filed Critical Advanced Immuni T Inc
Publication of IL149443A0 publication Critical patent/IL149443A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL14944300A 1999-11-09 2000-11-09 Compositions for treating viral diseases IL149443A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16436399P 1999-11-09 1999-11-09
PCT/US2000/042030 WO2001034095A2 (en) 1999-11-09 2000-11-09 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t

Publications (1)

Publication Number Publication Date
IL149443A0 true IL149443A0 (en) 2002-11-10

Family

ID=22594146

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14944300A IL149443A0 (en) 1999-11-09 2000-11-09 Compositions for treating viral diseases

Country Status (10)

Country Link
EP (1) EP1242109A4 (zh)
JP (1) JP2003528817A (zh)
KR (1) KR20020063182A (zh)
CN (1) CN1635913A (zh)
AU (1) AU3080001A (zh)
CA (1) CA2389392A1 (zh)
IL (1) IL149443A0 (zh)
MX (1) MXPA02004619A (zh)
WO (1) WO2001034095A2 (zh)
ZA (1) ZA200203120B (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242564B1 (en) * 1986-06-03 2001-06-05 Candace B. Pert Treatment of tropical spastic paresis with peptide T
EP0635027B1 (en) * 1992-03-27 2000-07-12 Advanced Immunit T,Inc. Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis

Also Published As

Publication number Publication date
AU3080001A (en) 2001-06-06
MXPA02004619A (es) 2004-09-10
ZA200203120B (en) 2002-11-27
WO2001034095A8 (en) 2001-11-29
KR20020063182A (ko) 2002-08-01
EP1242109A4 (en) 2004-06-02
CN1635913A (zh) 2005-07-06
EP1242109A2 (en) 2002-09-25
JP2003528817A (ja) 2003-09-30
WO2001034095A2 (en) 2001-05-17
CA2389392A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
EP1128832A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES
IL145470A0 (en) Compositions for the treatment of immune diseases
PL351134A1 (en) Compositions for treatment of disorders of the oesophagus
GB9925136D0 (en) Novel treatment
PL349347A1 (en) Novel treatment
EG22865A (en) Treatment compositions for fabrics
IL133760A0 (en) Composition for the treatment of dandruff
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
GB9900222D0 (en) Therapeutic compounds
GB2354944B (en) Skin treatment compositions
HK1046848A1 (en) Specific therapeutic composition for treating aids
IL151188A0 (en) Medicament for viral diseases
EP1203582A4 (en) MEDICINAL COMPOSITIONS FOR THE TREATMENT OF LOWER UROPATHY
GB0028484D0 (en) Imidazolone derivatives for the treatment of viral diseases
IL149443A0 (en) Compositions for treating viral diseases
HU9902296D0 (en) Pharmaceutical composition for treating caltification
GB2362827B (en) Pharmaceutical preparation for treating viral infections
IL132665A0 (en) Anti viral composition
HUP0003236A3 (en) Medicinal compositions for treating immunodeficiency diseases
GB9917160D0 (en) Maldour treatment compositions
HRPK20020201B1 (en) Pharmaceutical compositions for treating psoriasis
GB9905907D0 (en) Sterilant composition
GB9900428D0 (en) Virus inactivation process
GB9916655D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment